UnitedHealth's Commercial Costs Thwart Margin Recovery

UnitedHealth's (UNH) stock has risen about 34% over the past year, outperforming the S&P 500's 21%, on a recovery in margins that is only partway through. Two key factors driving this recovery are moving in opposite directions: while Medicare costs have improved, commercial costs continue to rise.

The company has intentionally prioritized margin discipline over top-line volume growth, which has slowed from 12% to 0.4%. With the top line flat, every dollar of earnings recovery must come from cost reduction. UnitedHealthcare expects a decline in Medicare Advantage enrollment by approximately 1.1 million through benefit adjustments and selective changes in market participation aimed at margin stability.

Medicare costs are improving due to the company's own benefit design, care management models, and network curation, as well as more favorable respiratory season and weather patterns. However, the company explicitly states that this improvement is not an inflection point in the trend.

The commercial side of the business is facing a different story, with costs running above 11%. The independent resolution process under the No Surprises Act, which applies only to commercial plans, is adding incremental trend and totaling at least 100 basis points of cost. UnitedHealth's management characterizes this process as inefficient, noting that dispute filings are heavily concentrated among a small number of provider groups.